New Key Statistics Module, Z-Score and F-Score
DHA:ORIONPHARM Key Ratios
Market Cap BDT M | 15,795.00 |
Enterprise Value BDT M | 37,883.75 |
P/E(ttm) | 34.68 |
PE Ratio without NRI | 34.70 |
Forward PE Ratio | -- |
Price/Book | 0.79 |
Price/Sales | 1.42 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.49 |
Revenue (TTM) BDT M | 11,758.00 |
EPS (TTM) BDT | 2.06 |
Beneish M-Score | -2.81 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -3.90 |
y-y EBITDA Growth Rate % | -35.40 |
EV-to-EBIT | 56.00 |
EV-to-EBITDA | 30.63 |
PEG | -- |
Shares Outstanding M | 234.00 |
Net Margin (%) | 4.08 |
Operating Margin % | 5.64 |
Pre-tax Margin (%) | 5.00 |
Quick Ratio | 1.36 |
Current Ratio | 1.51 |
ROA % (ttm) | 0.89 |
ROE % (ttm) | 2.29 |
ROIC % (ttm) | 1.23 |
Dividend Yield % | 1.47 |
Altman Z-Score | 0.91 |
Piotroski F-Score | 6.00 |
Positive ROA | Y |
Positive CFROA | Y |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | Y |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | N |
DHA:ORIONPHARM Number of Guru Trades
DHA:ORIONPHARM Volume of Guru Trades
Gurus Latest Trades with DHA:ORIONPHARM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DHA:ORIONPHARM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data